Corporate News
03 September
2026
Holy Young BioMedical Co., Ltd. ("Holy Young") announced that it officially entered into a cooperation agreement with Laboratoires Arkopharma (“Arkopharma”), a leading French natural health brand, on September 3, 2026, securing exclusive distribution rights for Taiwan.
Going forward, Holy Young will take full responsibility for the introduction of Arkopharma products into Taiwan, regulatory compliance, market development, channel expansion, brand building, and community engagement. Through Arkopharma’s official Taiwan online store and a diversified distribution network, Holy Young will progressively establish a complete and consistent local brand experience for Taiwanese consumers.
Over 40 Years of Expertise in Plant Science: Seeking Better Health Solutions from Nature
Founded in 1980 and headquartered in Carros in southern France, Arkopharma is a leading global company specializing in phytotherapy, natural nutritional supplements, and cosmetic products. Its products are available in more than 40 countries and regions worldwide.
Rather than focusing solely on the concept of “natural ingredients,” Arkopharma is dedicated to understanding the complexity and diversity of plants themselves. From botanical species selection, geographic origin, and optimal harvesting time to the medicinal plant part used, extraction process, concentration of active constituents, and formulation design, every critical factor that may influence product quality and performance is carefully controlled.
The brand summarizes decades of accumulated expertise under the concept of Precision Phytotherapy—an approach that combines botany, biology, pharmaceutical science, and advanced pharmaceutical technologies. It goes beyond simply “choosing the right plant” to identifying the right source, process, and dosage, creating a distinctive connection between nature and science.
In technological innovation, Arkopharma has developed several patented extraction technologies, including CRYO-Preserve, a special cryogenic grinding technology, and ULTRA-EXTRACT, an ultrasonic extraction technology, etc. These technologies are designed to maximize the preservation of naturally occurring active plant constituents under highly controlled conditions, helping ensure excellent product quality and stability.
More Than Plant Ingredients: Plant Science from Raw Material to Finished Product
For Arkopharma, plant science is not limited to ingredients. It is a rigorous, end-to-end scientific system. At the raw-material stage, the brand applies strict botanical identification procedures, traceable supply-chain controls, and contaminant management standards. During research, development, and manufacturing, Arkopharma further uses active-compound profiling and chemical testing, microbiological controls, process monitoring, and stability studies to comprehensively ensure product quality and safety.
This integrated approach, extending from plant selection through finished-product manufacturing, supports a broad portfolio covering multiple everyday health needs, including sleep and stress management, vitality, weight management, hair and nail care, circulation, digestive health, women’s health, joint care, and so forth.
Building Arkopharma’s Official Taiwan Brand Gateway and Local Consumer Experience
Holy Young introduces Arkopharma’s key product lines into Taiwan in phases, with close consideration of local consumer needs and applicable regulatory requirements.
Through localized product information, professional educational content, and channel collaboration, Holy Young aims to help consumers better understand product features, directions for use, the plant science behind the products, and their role in everyday health management.
The official Arkopharma Taiwan online store, https://www.arkopharma.com.tw/, is now live. The platform will bring together officially authorized products, brand stories, plant science knowledge, and practical wellness guidance, serving as an important gateway for Taiwanese consumers to discover the brand, access product information, and build greater awareness of daily health management.
Holy Young will also progressively connect the official online platform with physical retail channels and other business partners, creating a seamless online-to-offline brand experience.
From Personal Health to Environmental Sustainability: A Long-Term Commitment to Nature
Arkopharma has long integrated sustainability principles into its business operations, covering raw-material sourcing, manufacturing processes, packaging design, and supply-chain management.
The company continues to advance eco-design, optimize resource use, and improve supply-chain transparency in order to reduce its environmental impact.
Arkopharma is also one of the co-founding members of the Green Impact Index Consortium and obtained AFNOR CSR Certification – Confirmed Level in 2025, demonstrating its ongoing commitment to corporate social responsibility and sustainable business practices.
Bringing Together Leading French Plant Science and Local Taiwanese Expertise
This exclusive distribution partnership marks an important milestone in Arkopharma’s long-term development in Taiwan.
Arkopharma will contribute its advanced plant science expertise, product development capabilities, and strengths in French manufacturing, while Holy Young will bring its local regulatory expertise, distribution network development, brand marketing capabilities, and market insight. Together, the two companies aim to build a strong foundation for Arkopharma’s sustainable and long-term growth in Taiwan.
Looking ahead, both parties will continue to place science at the core and nature at the starting point, bringing French plant-based health concepts into the everyday lives of Taiwanese consumers in a way that is more approachable, easier to understand, and more accessible.
Through this partnership, Arkopharma and Holy Young aim to offer consumers in Taiwan a broader range of trusted options for everyday health management.
Nature, our expertise, your health.
深研自然，成就健康。
Photo Caption (taken at Arkopharma 🇫🇷)
Holy Young Biomedical Co., Ltd. representatives, CEO Yang Ching-Hua and VP Tsao Shou-Yu, with the Arkopharma team from International (Export), International (Marketing), Regulatory Affairs, and Manufacturing departments.
